- Charabi S, Tos M, Thomsen J, Charaibi B, Mantoni M. Vestibular schwannoma growth - long-term results. Acta Otolaryngol Suppl 2000: 543: 7-10.
- Charabi S, Tos M, Thomsen J, Charaibi B, Mantoni M. Vestibular schwannoma growth: the continuing controversy. Laryngoscope 2000: 110: 1720-5.
- Heine UI, Munoz EF, Flanders KC. Role of transforming growth factor-beta in the development of the mouse embryo. J Cell Biol 1987: 105: 2861-76.
- Roberts AB, Sporn MB. The transforming growth factor-betas. In: Sporn MB, Roberts AB, eds. Handbook of experimental pharmacology. Heidelberg, Germany: Springer-Verlag, 1990: 410-72.
- Labit-Bouvier C, Crebassa B, Bouvier C, Andrac-Meyer L, Magnan J, Charpin C. Clinicopathologic growth factors in vestibular schwannoma: a morphological and immunohistochemical study of 69 tumors. Acta Otolaryngol 2000: 120: 950-4.
- Cardillo MR, Filipo R, Monini S, Aliotta N, Barbara M. Transforming growth factor-betal expression in human acoustic neuroma. Am J Otol 1999; 20: 65-8.
- Kaasinen S, Pyykko I, Koskiniemi ML, Vaheri A. Culturing of acoustic neuroma: methodological aspects. Acta Otolaryngol Suppl (Stockh) 1995: 520: 25-6.
- Walsh RM, Bath AP, Bance ML, Keller A, Tator CH, Rutka JA. The natural history of untreated vestibular schwannoma. Is there a role for conservative management? Rev Laryngol Otol Rhinol 2000: 121: 21-6.
- Massik DD, Welling B, Dodson EE, et al. Tumor growth and audiometric change in vestibular schwannoma managed conservatively. Laryngoscope 2000; 110: 1843-9.
- Filipo R, Petrangeli E, Monini S, et al. Expression of steroid receptors in acoustic neuroma. Clin Otolaryngol 1995: 20: 413-7.
- Weerda HG, Gamberger TI, Siegner A, Gjuric M, Tamm ER. Effects of transforming growth factor-betal and basic fibroblast growth factor on proliferation of cell cultures derived from human vestibular nerve schwannoma. Acta Otolaryngol (Stockh) 1998; 118: 337-43.
- Bizzarri M, Cucina A, Valente MG, Stipa F, Tagliaferri F. Enhanced TGFß-I secretion and inhibition of breast cancer cell growth by combined treatment with Vitamin D3 and Melatonin. Neuroimmunomodulation 1999; 6: 454-5.
Release of Transforming Growth Factor Beta-1 in a Vestibular Schwannoma Cell Line
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.